FIELD: medicine. SUBSTANCE: described are anelated β carbolines of formula I: β wherein is R3 or group(s): -CO-R1, is R1- alkoxy; C1-C6 is R2, H2, alkyl, C1-C4 alkoxy-C1-C4 alkyl, A is 5 or 6 membered unsaturated cycle in which 1 or 2 atoms are substituted by N, O and/or S and which is substituted by C1-C2 or R5; R6 and R5 are identical or different and are H, R6, alkyl, C1-C6 alkyl which is substituted by hydroxyl or NR7R8, C1-C6 alkoxyl; phenyl, 5 or 6 membered heteroaryl residue which contains one or two N, O or S atoms, and phenyl and heteroaryl residue is substituted by C1-C4 alkyl, C1-C4 alkoxyl, halogen or C1-C4 together are R5 and R6 wherein n=4; (CH2)n, are h, R7 and R8 alkyl, acyl, and also isomers, tautomers and salts thereof. Compounds I are useful for improving cognitive functions. EFFECT: improved properties of the title compounds. 5 cl, 17 ex
Title | Year | Author | Number |
---|---|---|---|
HETERYLOXY-β-CARBOLINES AND METHOD OF PREPARATION THEREOF (VARIANTS) | 1993 |
|
RU2105766C1 |
DERIVATIVES OF 2,3-BENZODIAZEPINE, INTERMEDIATE COMPOUNDS FOR THEIR SYNTHESIS AND AGENT ELICITING INHIBITORY ACTIVITY WITH RESPECT TO AMPA-RECEPTORS | 1997 |
|
RU2179557C2 |
PROCESS FOR PREPARING DERIVATIVES OF BETA-CARBOLINE-3-CARBOXYLIC ACID | 0 |
|
SU1114335A3 |
5- OR 6-SUBSTITUTED ESTER OF β-CARBOLINE-3-CARBOXYLIC ACID SHOWING PSYCHOTROPIC ACTIVITY AND PHARMACEUTICAL PREPARATION FOR TREATMENT OF PSYCHOTROPIC DISEASES | 1991 |
|
RU2034845C1 |
METHOD OF PRODUCING DERIVATIVES OF BETA-CARBOLINE | 0 |
|
SU1376946A3 |
METHOD FOR PRODUCING BETA-CARBOLINES | 0 |
|
SU1318166A3 |
BICYCLIC 6-ALKYLIDENEPENEMS AS β-LACTAMASE INHIBITORS | 2003 |
|
RU2339640C2 |
AZABENZIMIDAZOLE COMPOUNDS AND A PHARMACEUTICAL COMPOSITION | 2019 |
|
RU2804485C2 |
DERIVATIVES OF DOLASTATIN-15 | 1998 |
|
RU2195462C2 |
METHOD OF PRODUCING DERIVATIVES OF BETA-CARBOLINE | 0 |
|
SU1376940A3 |
Authors
Dates
2001-06-20—Published
1996-04-03—Filed